Intraoperative Ophthalmic Imaging And Surgical Systems Market Size to Exceed USD 2,040.9 Mn by 2032

The Intraoperative Ophthalmic Imaging And Surgical Systems Market, estimated at USD 1,357.3 Mn in 2025, is expected to exhibit a CAGR of 6% and reach USD 2,040.9 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Intraoperative optical coherence tomography systems and technologies has been used to describe numerous vitreoretinal surgical diseases and treatments. Macular holes, epiretinal membranes, retinal detachments, and retinopathy of prematurity are a few of these conditions. Many of these intraoperative optical coherence tomography systems and technologies-identifiable diseases appear to undergo significant modifications during surgical interventions. Portable intraoperative optical coherence tomography systems and technologies probes that may be attached to a microscope or used handheld are the most often utilised systems.

Global Intraoperative Ophthalmic Imaging and Surgical Systems Market– Impact of Coronavirus (COVID-19) Pandemic

Since the outbreak of the COVID-19 epidemic in December 2025, the disease has spread to more than 100 countries worldwide and has been declared a public health emergency by the World Health Organization.The emergence of the coronavirus (COVID-19) had claimed more than 27 million lives worldwide, according to a report by the World Health Organization. The COVID pandemic has changed the homeostasis of the medical world and is affecting millions of people worldwide. The global crisis has consequences for the world economy in addition to health. According to the National Center for Biotechnology Information ( NCBI ), on February 17, 2025 conjunctivitis is the most common ophthalmic manifestation documented in COVID-19 patients. In a large series of cases with mild COVID-19 infection, reported that 11/127 (8.66%) patients had conjunctivitis. All symptomatic patients gave a history of redness of one or both eyes. Presence of respiratory tract symptoms were associated with conjunctival congestion. A positive history of hand-eye contact was elucidated in four patients; however, this did not attain clinical significance as a risk factor. This was different from the results of a cross-sectional study in 535 cases of COVID-19 patients which showed that hand-eye contact was independently correlated to the presence of conjunctival congestion amongst patients.

Global Intraoperative Ophthalmic Imaging and Surgical Systems Market: Key Developments

On April 2, 2025, an article published by Elsevier Journal, U.S., explaining the survey of ophthalmology which contains advanced technologies. Advanced Intraoperative optical coherence tomography systems and technologies had been evaluated in various experimental ex vivo and in vivo studies. Swept source–based iOCT systems enable acquisition of volumetric images and 3D rendering in real time. “Four-dimensional” (4D) imaging refers to live 3D imaging or 3D imaging over time. It utilizes ultra high-speed swept frequency centered at 1,040 nm, A-line rate of 100 kHz.

On June 2, 2025, an article published by Multidisciplinary Digital Publishing Institute, based in Switzerland, explained applications of Microscope Integrated Optical coherence tomography are subretinal injections for gene therapy, positioning of Argus II retinal prostheses, and guiding chorioretinal biopsies. In particular, subfoveal injection of AAV2-REP1 seems to be an increasingly popular treatment for patients affected by genetically confirmed advanced choroideremia, in order to achieve a sustained improvement or maintenance of visual acuity.

Browse 25 Market Data Tables and 28 figures spread through 150 pages and in-depth TOC on “Global Intraoperative Ophthalmic Imaging And Surgical Systems Market”- Forecast to 2032   Global Intraoperative Ophthalmic Imaging And Surgical Systems Market, By Product Type (Intra operative OCT, Intra operative Aberrometry, Image-Guided Systems, and Ophthalmic Surgical Microscopes), By End User (Hospitals, Ophthalmic Centers, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/intraoperative-ophthalmic-imaging-and-surgical-systems-market-3882

Key Takeaways of the Global Intraoperative Ophthalmic Imaging and Surgical Systems Market:

• Global Intraoperative Ophthalmic Imaging and Surgical Systems Market is expected to exhibit a CAGR of 6.0 % during the forecast period.
• It explores potential revenue opportunities in various segments and explains attractive investment proposition matrices for these markets
• This study also provides key insights into market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• The main companies involved in this study include ZEISS International, Novartis AG, Danaher Corporation, TrueVision, Haag-Streit Group, Clarity Medical Systems, Inc., Leica Microsystems, Optovue, Inc.
• The global intraoperative ophthalmic imaging and surgical systems market report serves various stakeholders in the industry, including investors, suppliers, pharmaceutical manufacturers, distributors, new entrants, and financial analysts.
• Various strategy matrices used in analyzing global intraoperative ophthalmic imaging and surgical systems market would facilitate stakeholders' decision-making.